Congress to Clinic: Continual Evolution of HER3 Targeting in NSCLC With Expert Perspectives on Clinical Advances and Practical Application

Explore expert insights on the newest data on use of HER3-targeted therapy for patients with advanced NSCLC. Listen to podcasts derived from a live event, and download the accompanying slides for a comprehensive reference on the latest advancements in clinical trials.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.